These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2453592)

  • 1. A double determinant radioimmunoassay Mov2-MOv8 for monitoring ovarian carcinomas: definition of the methodology.
    Diotti A; Santoro O; Mantovani L; Regazzoni M; Fontanelli R; Ravagnani F; Miotti S; Ménard S; Colnaghi MI
    Int J Biol Markers; 1987; 2(3):161-8. PubMed ID: 2453592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of Lewis(a) antigen in sera of ovarian carcinoma patients by MOv2-MOv8 double-determinant radioimmunoassay.
    Mantovani L; Azzini V; Canevari S; Danzi R; Fontanelli R; Leoni F; Ménard S; Miotti S; Pasquali M; Zambetti M
    Int J Biol Markers; 1989; 4(4):197-202. PubMed ID: 2483408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunochemical characterization and radioimmunometric detection of molecules shed by human ovarian cancer.
    Leoni F; Bast RC; Canevari S; Menard S; Soper JT; Colnaghi MI
    Int J Cancer; 1987 Nov; 40(5):592-7. PubMed ID: 2445699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating DF3 and CA125 antigen levels in serum from patients with epithelial ovarian carcinoma.
    Sekine H; Hayes DF; Ohno T; Keefe KA; Schaetzl E; Bast RC; Knapp R; Kufe DW
    J Clin Oncol; 1985 Oct; 3(10):1355-63. PubMed ID: 2413181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A monoclonal antibody RIA as an antigenic determinant (CA 125) in ovarian cancer patients].
    Lian LJ
    Zhonghua Fu Chan Ke Za Zhi; 1985 Sep; 20(5):257-60, 317. PubMed ID: 2417787
    [No Abstract]   [Full Text] [Related]  

  • 6. Biochemical analysis of human ovarian cancer-associated antigens defined by murine monoclonal antibodies.
    Miotti S; Aguanno S; Canevari S; Diotti A; Orlandi R; Sonnino S; Colnaghi MI
    Cancer Res; 1985 Feb; 45(2):826-32. PubMed ID: 2981614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human carcinoma cell lines xenografted in athymic mice: biological and antigenic characteristics of an intraabdominal model.
    Ripamonti M; Canevari S; Ménard S; Mezzanzanica D; Miotti S; Orlandi R; Rilke F; Tagliabue E; Colnaghi MI
    Cancer Immunol Immunother; 1987; 24(1):13-8. PubMed ID: 3545465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A monoclonal antibody radioimmunoassay for an antigenic determinant CA125 in ovarian cancer patients.
    Lian LJ; Hu XF; Liu WS; Wu AJ
    Chin Med J (Engl); 1986 Sep; 99(9):721-6. PubMed ID: 2433106
    [No Abstract]   [Full Text] [Related]  

  • 9. Monitoring human ovarian carcinoma with a combination of CA 125, CA 19-9, and carcinoembryonic antigen.
    Bast RC; Klug TL; Schaetzl E; Lavin P; Niloff JM; Greber TF; Zurawski VR; Knapp RC
    Am J Obstet Gynecol; 1984 Jul; 149(5):553-9. PubMed ID: 6204531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of monoclonal antibodies reacting with human epithelial ovarian cancer.
    Tagliabue E; Mènard S; Della Torre G; Barbanti P; Mariani-Costantini R; Porro G; Colnaghi MI
    Cancer Res; 1985 Jan; 45(1):379-85. PubMed ID: 3965146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of human ovarian carcinoma-associated antigens defined by novel monoclonal antibodies with tumor-restricted specificity.
    Miotti S; Canevari S; Ménard S; Mezzanzanica D; Porro G; Pupa SM; Regazzoni M; Tagliabue E; Colnaghi MI
    Int J Cancer; 1987 Mar; 39(3):297-303. PubMed ID: 2434438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibodies against human ovarian tumor associated antigen NB/70K: preparation and use in a radioimmunoassay for measuring NB/70K in serum.
    Knauf S; Kalwas J; Helmkamp BF; Harwell LW; Beecham J; Lord EM
    Cancer Immunol Immunother; 1986; 21(3):217-25. PubMed ID: 2421899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical characterization of ovarian borderline tumors of intestinal and mullerian types.
    Rutgers JL; Bell DA
    Mod Pathol; 1992 Jul; 5(4):367-71. PubMed ID: 1495942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CA125 antigen levels in obstetric and gynecologic patients.
    Niloff JM; Knapp RC; Schaetzl E; Reynolds C; Bast RC
    Obstet Gynecol; 1984 Nov; 64(5):703-7. PubMed ID: 6208522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OVX1 radioimmunoassay complements CA-125 for predicting the presence of residual ovarian carcinoma at second-look surgical surveillance procedures.
    Xu FJ; Yu YH; Daly L; DeSombre K; Anselmino L; Hass GM; Berchuck A; Soper JT; Clarke-Pearson DL; Boyer C
    J Clin Oncol; 1993 Aug; 11(8):1506-10. PubMed ID: 8336189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Change in binding reactivity of an anti-tumor monoclonal antibody after the introduction of 2-pyridyl disulphide groups.
    Orlandi R; Canevari S; Leoni F; Mezzanzanica D; Ripamonti M; Colnaghi MI
    Hybridoma; 1986; 5(1):1-8. PubMed ID: 3957358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibodies recognizing tumor-associated antigen of human ovarian mucinous cystadenocarcinomas.
    Bhattacharya M; Chatterjee SK; Barlow JJ; Fuji H
    Cancer Res; 1982 May; 42(5):1650-4. PubMed ID: 6175395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experiences with CA 125, a tumor marker for malignant epithelial ovarian tumors].
    Crombach G; Zippel HH; Würz H
    Geburtshilfe Frauenheilkd; 1985 Apr; 45(4):205-12. PubMed ID: 2408962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selection of a monoclonal antibody reactive with a high-molecular-weight glycoprotein circulating in the body fluid of gastrointestinal cancer patients.
    Sakurai Y; Hirohashi S; Shimosato Y; Kodaira S; Abe O
    Cancer Res; 1988 Jul; 48(14):4053-8. PubMed ID: 2454734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the specificity by immunohistology of a monoclonal antibody to a novel epithelial antigen of ovarian carcinomas.
    Mariani-Costantini R; Agresti R; Colnaghi MI; Ménard S; Andreola S; Rilke F
    Pathol Res Pract; 1985 Aug; 180(2):169-80. PubMed ID: 3903701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.